HealthInvestor Asia Summit 2018
Financial intelligence for Asia's healthcare markets
Remember me:

Analysis: Medical tourism continues to grow

Bart Van den Mooter, CEO of the TforG Group, looks at the drivers behind the rapid growth in Asia’s medical tourism market.

Asia Pacific is the fastest-growing region in the global medtech market. This growth is fuelled by public healthcare reforms, but even more so by the rapidly expanding private sector and with medical tourism, a connection not often made when the booming medtech market is talked about.

In most Association of Southeast Asian Nations countries, medical tourism represents a third or more of private hospital revenues. With every country looking to extract a piece of this pie, competition between countries and hospitals is intensifying.

In 2016, between 105 and 120 million medical tourists travelled abroad to seek healthcare services. This number is expected to grow by 10-14% annually in the coming three years. Worldwide medical tourism generated €150 billion (US$177 billion) in 2016 and is expected to grow to €200 billion by 2020.

The southeast Asian healthcare market is expanding faster than in other regions, especially driven by the private sector and, notably, medical tourism. Foreign patients are a major revenue generator for private hospitals in the region. Their share represents 40-55% of the private hospitals’ revenue in countries such as Singapore, Malaysia and especially Thailand. In India, medical tourism accounts for 25% of revenue, and in the Philippines, South Korea and Taiwan, it accounts for 10-15% of revenue.

In 2016, the medical tourism sector in Asia Pacific accounted for 10 million patients and €15-17 billion in revenues. For instance, India attracted more than 4 million medical tourists in 2016, generating around €4 billion in healthcare revenues. Similarly, in Thailand, which has perhaps the most advanced medical tourism sector, 3.5 million foreign patients spent more than €4 billion on healthcare in 2016. In Singapore, medical tourism accounted for almost €1.6 billion with close to 900,000 patients in 2016.

The sector will continue to grow 15-17% annually for the coming three years.

Due to fierce competition, private hospitals in the region regularly upgrade facilities and increase capacity. Recently, the sector has started attracting more international hospital groups and investors seeking to enter this lucrative market.

Countries seeking to develop medical tourism are teaming up with large multinational players – for example, Mayo Clinic with Raffles Medical Group in Singapore, Cleveland Clinic Abu Dhabi, John Hopkins Singapore and Anadolo Medical Centre in Turkey. While increasing competition between care providers is leading to differentiating investments and services, it is also leading to increased cost pressure and dilution in quality of healthcare.

The growth of medical tourism in southeast Asia obviously impacts the medtech market. Southeast Asia and India together represent more than €50 billion, or more than 10% of the global medtech market, and are growing faster (7.5%) than any other region in the world.

Market dynamics in the healthcare tourism segment impact the providers of medical equipment and devices in terms of product offerings and customer services. It also creates new opportunities for global as well as local medtech companies. With recent trends, there has been a shift to more day-care and ambulatory procedures in order to deal with staff shortages and cost-effectiveness.

There is also an increased need for telemedicine and e-health to improve the continuum of care. In recent times, medtech companies have increased group purchasing  and central warehousing and are also offering innovative IT-based and value-chain solutions to improve or defend their competitive advantage. They are also shifting from product-focused offerings to customised value-based solutions.

Both push factors and pull factors explain why the medical tourism market has taken off in the region and continues to grow.

Wealthy patients in emerging countries seek high-quality care in high-standard settings, which medical tourism destinations can offer. Middle class and underinsured patients in developed countries feel disenfranchised by their national healthcare systems, which are often plagued by long waiting times for treatments. They shop outside the organised medical system to find services that are affordable, timely or simply available.

Healthcare insurers motivate patients to seek more cost-effective medical provisions outside their home countries, and the usually lower cost of medical treatment in medical tourism destinations is an obvious attraction.

Moreover, national health insurance in developed countries does not typically cover some types of care, such as cosmetic surgery and dental care.

On the other hand, triggered by the opportunities of medical tourism, governments actively promote their countries and hospitals for patients shopping for healthcare services. Healthcare providers deploy referral systems to attract patients, and service companies offer innovative products to guide patients in their choice of country and hospital. To meet this demand, entrepreneurs are building technologically advanced facilities using foreign and domestic capital. They are hiring physicians, technicians and nurses trained to international standards, and where qualified personnel are not available locally, they are recruiting expatriates. Additionally, new service providers in these markets are also offering state-of-the-art healthcare technology for patients.

The increasing affordability of international air fares for intercontinental travel has also played a role in supporting the growth of the regional medical tourism market.

Finally, many nations in the region regard medical tourism as a resource for economic development; for instance, the ministries of tourism in Thailand, Malaysia and India have been aggressively and fiercely promoting medical tourism in their countries. In the same vein, private hospital chains and investors perceive medical tourism in Asia Pacific as an attractive business opportunity and invest in infrastructure, equipment, staff and services.

The market is not without its challenges. Chief among them are political stability. Political stability is a requisite to draw any international tourists, irrespective of whether they are travelling for leisure or medical treatment. For instance, political unrest in Thailand and in some Malaysian provinces had an impact, albeit temporary, on medical tourism in these countries. 

But staff shortages also play a role. The volume of adequately trained clinical staff (doctors and nurses) can hardly keep up with the growing numbers of medical tourists and the level and quality of care they expect. Hospitals hire physicians abroad or collaborate with western hospitals to deal with the shortage. At the same time, they review their operational processes and invest in equipment and solutions that impact the productivity of the hospital.

Significant too is competitiveness and cost pressure. The increasing number of hospitals and investors offering global healthcare services creates in competition between countries, often resulting in price wars that can potentially dilute the quality of healthcare provided.

The medical tourism market in ASEAN is in the midst of a boom, and this is impacting the medtech market, among others. For stakeholders that can mitigate these and other operational challenges, the opportunity is abundant. Much of their success, however, will depend on how governments and the private sector can work together to create a conducive medical tourism ecosystem.

This article first appeared on BRINK Asia

Posted on: 08/11/2017 UTC+08:00


Paragon Care, a leading distributor and manufacturer supplying medical equipment to hospitals, is to raise A$69.8 million (US$54.6 million) in a fully underwritten offer on the ASX.
Parkway Life REIT, which is owned by IHH Healthcare, is to acquire Konosu Nursing Home Kyoseien, a nursing rehabilitation facility in Greater Tokyo, under a sale-and-leaseback agreement with Iryouhoujin Shadan Kouaikai for ¥1.5 billion (US$13.7 million).
New Zealand-based cancer diagnostics company Pacific Edge (PEB) has entered into an agreement with MediNcrease Health Plans, a US national provider network, to make its bladder cancer diagnostic test available.
Beijing-based paediatric centre Dr Cuiyutao Healthcare has raised Series C plus funding led by New Oriental Education & Technology Group. The size of the funding has not been disclosed, but is understood to be in the millions of US dollars.
Kelantan-based Ain Medicare, which manufactures both blood and renal medical devices as well as pharmaceutical products, has raised M$20 million (US$5.1 million) in a strategic investment from Malaysian government investment company A-BIO.
Anthea Muir has been named chief executive of Australian cosmetic clinic chain Laser Clinics Australia with Paul McClintock as chairman. Muir comes from Luxottica Group while McClintock is best known as the former chairman of Medibank Private.
Harmonicare Medical, the largest private obstetrics and gynaecology specialty hospital group in China, has increased its loan to help the Rmb160 million (US$25.3 million) construction of Wuxi Harmonicare, a new obstetrics and gynaecology hospital in Wuxi, Jiangsu Province.
Higher sales have given a boost to third quarter results at medical rubber glove manufacturer Hartalega Holdings.


A new paper from KPMG looks at the disconnect between consumer expectations and the current healthcare experience of patients in Australia.
Gan Kim Yong, Singapore’s minister for health, explains why integrated care is important in the context of an ageing population.
Not having featured before 2015, Chinese investment in Australia’s healthcare sector has surged over the past three years. It has reached A$5.5 billion (US$4.5 billion) across 16 completed deals, according to a new report from KPMG and The University of Sydney Business School.
Michael Griffiths, regional director of healthcare at specialist insurance brokers Howden, explains how insurance is an answer to the region’s healthcare crisis.
Nomaan Mirza, principal equity specialist at the International Finance Corporation, looks at healthcare equity opportunities in emerging markets.
The healthcare industry in Asia-Pacific is expected to grow at 11.1% in 2018, representing one of the fastest growing regions in the world, as the global healthcare economy averages a 4.8% annual growth rate.
Technologist, business leader, and philanthropist Bill Gates explains why global health needs the private sector.
Mitch Beaumont, Prashanth Prasad, Ulrica Sehlstedt and Mandeep Dhillon from international management consultants Arthur D. Little explain how medical technology companies can manage going digital.
my images


Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices